| Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing PJ Whiley, M De La Hoya, M Thomassen, A Becker, R Brandão, ... Clinical chemistry 60 (2), 341-352, 2014 | 84 | 2014 |
| Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers I Blanco, K Kuchenbaecker, D Cuadras, X Wang, D Barrowdale, ... PloS one 10 (4), e0120020, 2015 | 78 | 2015 |
| Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples JD Fackenthal, T Yoshimatsu, B Zhang, GR de Garibay, M Colombo, ... Journal of medical genetics 53 (8), 548-558, 2016 | 63 | 2016 |
| Fission yeast rgf2p is a rho1p guanine nucleotide exchange factor required for spore wall maturation and for the maintenance of cell integrity in the absence of rgf1p P Garcia, I Garcia, F Marcos, GR de Garibay, Y Sánchez Genetics 181 (4), 1321-1334, 2009 | 42 | 2009 |
| Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1 G Hernández, MJ Ramírez, J Minguillón, P Quiles, G Ruiz de Garibay, ... Nature communications 9 (1), 967, 2018 | 41 | 2018 |
| Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition F Mateo, EJ Arenas, H Aguilar, J Serra-Musach, GR De Garibay, J Boni, ... Oncogene 36 (19), 2737-2749, 2017 | 41 | 2017 |
| About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants S Gutiérrez‐Enríquez, S Bonache, G Ruíz de Garibay, A Osorio, ... International journal of cancer 134 (9), 2088-2097, 2014 | 40 | 2014 |
| Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31 BRCA2 Genetic Variants GR de Garibay, A Acedo, Z García‐Casado, S Gutiérrez‐Enríquez, ... Human mutation 35 (1), 53-57, 2014 | 33 | 2014 |
| Intracellular cytidine deaminase regulates gemcitabine metabolism in pancreatic cancer cell lines TK Bjånes, LP Jordheim, J Schjøtt, T Kamceva, E Cros-Perrial, A Langer, ... Drug Metabolism and Disposition 48 (3), 153-158, 2020 | 28 | 2020 |
| Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families GR De Garibay, A Díaz, B Gavina, A Romero, P Garre, A Vega, A Blanco, ... European Journal of Human Genetics 21 (8), 883-886, 2013 | 28 | 2013 |
| Modification of BRCA1-associated breast cancer risk by HMMR overexpression F Mateo, Z He, L Mei, GR de Garibay, C Herranz, N García, A Lorentzian, ... Nature communications 13 (1), 1895, 2022 | 25 | 2022 |
| BRCA1 Alternative splicing landscape in breast tissue samples A Romero, F García-García, I López-Perolio, G Ruiz de Garibay, ... BMC cancer 15, 1-8, 2015 | 25 | 2015 |
| Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness G Ruiz de Garibay, C Herranz, A Llorente, J Boni, J Serra-Musach, ... PLoS One 10 (7), e0132546, 2015 | 23 | 2015 |
| Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women MY Sun, HY Du, AN Zhu, HY Liang, GR De Garibay, FX Li, M Li, XX Yang International Journal of Molecular Sciences 16 (2), 4121-4135, 2015 | 22 | 2015 |
| Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer MK Moutafi, M Molero, SM Morilla, J Baena, IA Vathiotis, N Gavrielatou, ... Journal for immunotherapy of cancer 10 (8), 2022 | 18 | 2022 |
| An A91V SNP in the Perforin Gene Is Frequently Found in NK/T-Cell Lymphomas R Manso, SM Rodríguez-Pinilla, L Lombardia, G Ruiz de Garibay, ... PLoS One 9 (3), e91521, 2014 | 17 | 2014 |
| Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the … G Ruiz de Garibay, S Gutiérrez-Enríquez, P Garre, S Bonache, A Romero, ... Breast cancer research and treatment 133, 273-283, 2012 | 17 | 2012 |
| Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance G Ruiz de Garibay, F Mateo, A Stradella, R Valdes-Mas, L Palomero, ... Disease models & mechanisms 11 (5), dmm032292, 2018 | 16 | 2018 |
| Study of breast cancer incidence in patients of lymphangioleiomyomatosis O Nuñez, A Román, SR Johnson, Y Inoue, M Hirose, Á Casanova, ... Breast Cancer Research and Treatment 156, 195-201, 2016 | 12 | 2016 |
| Cancer network activity associated with therapeutic response and synergism J Serra-Musach, F Mateo, E Capdevila-Busquets, GR de Garibay, ... Genome medicine 8, 1-12, 2016 | 10 | 2016 |
